Magnesium sulfate heptahydrate IBE

Medicinal product

(Invented) name

Magnesium sulfate heptahydrate IBE

Active substance (s)

Magnio sulfatas heptahidratas

Strength

250 mg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B05XA05, Magnesium sulfate

Marketing authorisation holder

UAB Eletis Pharma, Lietuva

Date of authorisation

2017-07-19

Date of renewal

2022-02-10

Documents

4110 Magnesium sulfate heptahydrate IBE RPP 2024 04 16.docx

4110 Pakuotės lapelis 2024 04 16.docx

Magnio sulfatas IBE_viešas AR.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Magnio sulfatas heptahidratas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68815	83398	1083398	ampulė	5 ml N10		Receptinis	LT/1/17/4110/001	Netiekiama	-	-	No	-	-
68816	83399	1083399	ampulė	10 ml N5		Receptinis	LT/1/17/4110/002	Netiekiama	-	-	No	-	-
97693	83788	1083788	ampulė	10 ml N10		Receptinis	LT/1/17/4110/003	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-02-10	Perregistruotas
2017-07-19	Registruotas